2015 Promise Ball Youth Ambassador Applications

                You are invited to apply for the 2015 Promise Ball, The Best is Yet to Come Youth Ambassador Program!  Each year, this black tie event welcomes over 800 guests and raises over $1.2 million for JDRF-funded research.  This year The 2015 Promise Ball features a glamorous evening […]

It’s Time to Redefine Type 1 Diabetes

A new study is further assessing if a novel combination of drugs could help treat new onset type 1 diabetes Last month, JDRF co-hosted a workshop where healthcare experts from government, nonprofit agencies and educational institutions discussed expanding the definition of Type 1 Diabetes (T1D) to recognize the earliest stages of human T1D before a […]

Unlocking a Combination Therapy for New Onset T1D

A new study is further assessing if a novel combination of drugs could help treat new onset type 1 diabetes University of Florida researchers are ready to launch a new clinical study to examine if a combination of two U.S Food and Drug Administration (FDA) approved drugs, antithymocyte globulin (ATG) and granulocyte colony stimulating factor […]

Mazda Drive for Good

Special thanks to our friends at Mazda for including JDRF Houston as one of their local Drive for Good charities!  Mazda Drive for Good™ is an annual way of making a difference by donating money and time to worthy causes in the local community.  When you test drive a Mazda between now and January 2, […]

A song worth more than a listen

Korn releases exclusive download to benefit T1D research What can one voice raised against type 1 diabetes (T1D) do? If you’re Jonathan Davis, lead singer of acclaimed rock band Korn, one voice can reach millions to help people living with T1D. Jonathan’s young son, Zeppelin, was diagnosed with T1D just over a year ago, and […]

Help JDRF Houston win $50,000!

JDRF has a chance to win $50,000 in the Chevron Houston Marathon Run for a Reason program.  Please take a minute and vote for JDRF.  And then – pass it on and ask your friends to vote too!  It is quick and easy to cast your vote.   http://www.hmcpresscenter.com/featured/vote-for-your-favorite-chevron-houston-marathon-run-for-a-reason-charity-3/   Thank you for your help!

Advancing a Key Artificial Pancreas Technology

Stable liquid glucagon developed by JDRF partner Xeris evaluated in first clinical study The JDRF Artificial Pancreas (AP) project is focused on accelerating the development of commercially-viable AP systems that better mimic the biological function of the pancreas and reduce the daily burden of managing type 1 diabetes (T1D). To achieve this goal, JDRF funds […]

Improving Beta Cell Health and Survival

JDRF-funded clinical study to test marketed drug to improve beta cell health and survival in T1D JDRF recently awarded a $2.1 million grant to Anath Shalev, M.D., director of the University of Alabama’s (UAB) Comprehensive Diabetes Center, to test the impact of a common blood pressure drug called verapamil on the health and survival of […]

Historic Progress for JDRF Encapsulation Research Program

First people with type 1 diabetes receive experimental encapsulated cell replacement therapies in clinical studies Two JDRF-funded partners have successfully implanted people with type 1 diabetes (T1D) with experimental encapsulated cell replacement therapies in clinical studies. These two programs are running in parallel and are evaluating two distinct encapsulation therapies. Encapsulated cell replacement therapy involves […]